• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据快速癌症治疗途径的要求,考虑治疗步骤,对前列腺癌患者诊断和治疗的等待时间进行分析。

An Analysis of Waiting Times for the Diagnosis and Treatment of Patients with Prostate Cancer Established by the Requirements of the Fast-Track Cancer Treatment Pathway, Taking into Account Treatment Steps.

作者信息

Sierocka Aleksandra, Brzozowski Stanisław, Marczak Michał, Bednarek Mariusz, Kozłowski Remigiusz

机构信息

Department of Management and Logistics in Healthcare, Medical University of Lodz, 90-419 Lodz, Poland.

Department of Management, SAN University in Lodz, 90-113 Lodz, Poland.

出版信息

Cancers (Basel). 2025 May 31;17(11):1842. doi: 10.3390/cancers17111842.

DOI:10.3390/cancers17111842
PMID:40507323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12153762/
Abstract

UNLABELLED

Prostate cancer is the most common cancer in men in 112 countries, accounting for 1 in 14 diagnosed cancer cases worldwide. For this reason, the diagnosis and treatment of prostate cancer changed significantly, becoming a multidisciplinary process. Since 2015 in Poland, measures have been taken to accelerate the diagnosis and treatment of cancers, including shortening patients' diagnosis and treatment waiting times.

BACKGROUND/OBJECTIVES: The aim of this study was to characterize the current clinical pathway of patients with prostate cancer and to establish standard times for various steps of treatment, as well as to develop a visualization of the steps involved in diagnosis and treatment.

METHODS

The research covers 2018 to 2022 in a large oncological hospital in Poland (EU area). The source data, in the form of 10 fully anonymized CSV files generated from the hospital's medical statistics, have been converted to the target data model.

RESULTS

The time limits for diagnosing and commencing the treatment of patients with diagnosed prostate cancer specified by legal regulations and by guidelines of scientific associations are not met in 42% of cases. The greatest delays concern the initiation of the steps of treatment (53%) and comprehensive diagnostics (37%). The diagnostic pathways should be modified to facilitate early and rapid detection of prostate cancer and to allow further therapy within the time limit strictly defined by regulations and guidelines of scientific associations.

摘要

未标注

前列腺癌是112个国家男性中最常见的癌症,占全球确诊癌症病例的十四分之一。因此,前列腺癌的诊断和治疗发生了显著变化,成为一个多学科过程。自2015年以来,波兰已采取措施加快癌症的诊断和治疗,包括缩短患者的诊断和治疗等待时间。

背景/目的:本研究的目的是描述前列腺癌患者当前的临床路径,确定治疗各步骤的标准时间,并绘制诊断和治疗步骤的可视化图。

方法

该研究涵盖2018年至2022年波兰一家大型肿瘤医院(欧盟地区)的情况。源数据以医院医疗统计生成的10个完全匿名的CSV文件形式存在,已转换为目标数据模型。

结果

在42%的病例中,法规和科学协会指南规定的前列腺癌确诊患者的诊断和开始治疗的时间限制未得到满足。最大的延迟涉及治疗步骤的启动(53%)和全面诊断(37%)。应修改诊断路径,以促进前列腺癌的早期快速检测,并在法规和科学协会指南严格规定的时间内进行进一步治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/669e5da9ebd7/cancers-17-01842-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/408d94d6830e/cancers-17-01842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/376068472a58/cancers-17-01842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/8901290d21b8/cancers-17-01842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/100e0b7bb88a/cancers-17-01842-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/260f0b99e180/cancers-17-01842-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/1be5be35b5ce/cancers-17-01842-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/669e5da9ebd7/cancers-17-01842-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/408d94d6830e/cancers-17-01842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/376068472a58/cancers-17-01842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/8901290d21b8/cancers-17-01842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/100e0b7bb88a/cancers-17-01842-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/260f0b99e180/cancers-17-01842-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/1be5be35b5ce/cancers-17-01842-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82a3/12153762/669e5da9ebd7/cancers-17-01842-g007.jpg

相似文献

1
An Analysis of Waiting Times for the Diagnosis and Treatment of Patients with Prostate Cancer Established by the Requirements of the Fast-Track Cancer Treatment Pathway, Taking into Account Treatment Steps.根据快速癌症治疗途径的要求,考虑治疗步骤,对前列腺癌患者诊断和治疗的等待时间进行分析。
Cancers (Basel). 2025 May 31;17(11):1842. doi: 10.3390/cancers17111842.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
4
The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.在全科医疗中,直接转诊进行快速CT扫描对早期肺癌检测的效果。一项临床、整群随机试验。
Dan Med J. 2015 Mar;62(3).
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
The Waiting Time of Prostate Cancer Patients in Poland.波兰前列腺癌患者的等待时间。
Int J Environ Res Public Health. 2019 Jan 26;16(3):342. doi: 10.3390/ijerph16030342.
7
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
8
Waiting Times in Prostate Cancer Diagnosis and Treatment: A Ten-Year Experience in A Nigerian Teaching Hospital.前列腺癌诊断和治疗中的等待时间:尼日利亚一所教学医院的十年经验。
West Afr J Med. 2024 Mar 29;41(3):317-321.
9
Survival in men diagnosed with prostate cancer in Poland in the years 2000 - 2014 compared to European Countries based on Concord-3.2000-2014 年波兰与欧洲国家男性前列腺癌患者生存情况比较——基于 Concord-3 研究
Rocz Panstw Zakl Hig. 2020;71(4):445-453. doi: 10.32394/rpzh.2020.0143.
10
Vesicoureteral Reflux膀胱输尿管反流

本文引用的文献

1
The Sankey diagram: An exploratory application of a data visualization tool.桑基图:一种数据可视化工具的探索性应用。
Transfusion. 2024 Jun;64(6):967-968. doi: 10.1111/trf.17803. Epub 2024 Apr 12.
2
An In-Depth Look Into the Epidemiological and Etiological Aspects of Prostate Cancer: A Literature Review.深入探究前列腺癌的流行病学和病因学方面:文献综述
Cureus. 2023 Nov 4;15(11):e48252. doi: 10.7759/cureus.48252. eCollection 2023 Nov.
3
Practicalities, challenges and solutions to delivering a national organisational survey of cancer service and processes: Lessons from the National Prostate Cancer Audit.
实现全国性癌症服务和流程组织调查的实际情况、挑战和解决方案:来自全国前列腺癌审计的经验教训。
J Cancer Policy. 2022 Sep;33:100344. doi: 10.1016/j.jcpo.2022.100344. Epub 2022 Jun 17.
4
Re: Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients with Localized Prostate Cancer: Results from the FLAME Randomized Phase III Trial.回复:局部前列腺癌患者外照射放疗中前列腺内肿瘤的局部增强:FLAME随机III期试验结果
Eur Urol. 2022 May;81(5):544-545. doi: 10.1016/j.eururo.2022.01.015. Epub 2022 Jan 31.
5
Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021.前列腺特异性抗原检测作为前列腺癌风险适应性早期检测策略的一部分:欧洲泌尿外科学会2021年立场与建议
Eur Urol. 2021 Dec;80(6):703-711. doi: 10.1016/j.eururo.2021.07.024. Epub 2021 Aug 15.
6
Public reporting of outcomes in radiation oncology: the National Prostate Cancer Audit.放射肿瘤学治疗结果的公开报告:国家前列腺癌审计
Lancet Oncol. 2021 May;22(5):e207-e215. doi: 10.1016/S1470-2045(20)30558-1. Epub 2021 Mar 4.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes?系统评价:中危和高危前列腺癌的确定性治疗时间:延迟是否与预后更差相关?
J Urol. 2021 May;205(5):1263-1274. doi: 10.1097/JU.0000000000001601. Epub 2021 Jan 14.
9
Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume.前列腺特异性抗原密度与病理性显著前列腺癌的关系:前列腺体积的影响。
Prostate. 2020 Dec;80(16):1444-1449. doi: 10.1002/pros.24078. Epub 2020 Sep 24.
10
Exploring Patient Path Through Sankey Diagram: A Proof of Concept.通过桑基图探索患者路径:概念验证
Stud Health Technol Inform. 2020 Jun 16;270:218-222. doi: 10.3233/SHTI200154.